Published in J Invest Dermatol on September 23, 2010
TSLP elicits IL-33-independent innate lymphoid cell responses to promote skin inflammation. Sci Transl Med (2013) 2.64
Rhinovirus-induced IL-25 in asthma exacerbation drives type 2 immunity and allergic pulmonary inflammation. Sci Transl Med (2014) 2.56
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11
One remarkable molecule: filaggrin. J Invest Dermatol (2011) 2.10
Th2 Cytokines and Atopic Dermatitis. J Clin Cell Immunol (2011) 1.91
T cell homing to epithelial barriers in allergic disease. Nat Med (2012) 1.58
The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology (2011) 1.53
Skin barrier disruption: a requirement for allergen sensitization? J Invest Dermatol (2012) 1.40
Epidermal barrier dysfunction and cutaneous sensitization in atopic diseases. J Clin Invest (2012) 1.38
Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunol (2012) 1.02
Innate lymphoid cells and allergic inflammation. Curr Opin Immunol (2013) 1.00
Cytokines and the skin barrier. Int J Mol Sci (2013) 0.96
Advances in atopic dermatitis. Curr Opin Immunol (2011) 0.95
Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep (2014) 0.91
Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J Allergy Clin Immunol (2015) 0.91
IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice. PLoS One (2015) 0.88
State-of-the-art review about basophil research in immunology and allergy: is the time right to treat these cells with the respect they deserve? Blood Transfus (2011) 0.88
Group 2 innate lymphoid cells in health and disease. Cold Spring Harb Perspect Biol (2015) 0.84
IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol (2013) 0.81
HSP: Bystander Antigen in Atopic Diseases? Front Immunol (2012) 0.81
Epidermal tight junctions in health and disease. Tissue Barriers (2015) 0.78
Type 2 innate lymphoid cells: friends or foes-role in airway allergic inflammation and asthma. J Allergy (Cairo) (2012) 0.77
Filaggrin loss-of-function mutations and atopic dermatitis as risk factors for hand eczema in apprentice nurses: part II of a prospective cohort study. Contact Dermatitis (2013) 0.76
Type-2 innate lymphoid cells in asthma and allergy. Ann Am Thorac Soc (2014) 0.76
Resveratrol ameliorates 2,4-dinitrofluorobenzene-induced atopic dermatitis-like lesions through effects on the epithelium. PeerJ (2016) 0.75
Atopic Dermatitis Studies through In Vitro Models. Front Med (Lausanne) (2017) 0.75
[New advances in atopic dermatitis]. Hautarzt (2012) 0.75
Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics (2009) 1.75
Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model. Mol Ther (2008) 1.47
Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection. Cell Microbiol (2007) 1.40
Increased interleukin 21 (IL-21) and IL-23 are associated with increased disease activity and with radiographic status in patients with early rheumatoid arthritis. J Rheumatol (2010) 1.24
Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol (2008) 1.21
The expression of IL-20 and IL-24 and their shared receptors are increased in rheumatoid arthritis and spondyloarthropathy. Cytokine (2007) 1.16
A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. Springerplus (2013) 1.07
Expression of MDC/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine (2009) 0.96
TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells. J Immunol (2009) 0.95
MK2 regulates the early stages of skin tumor promotion. Carcinogenesis (2009) 0.95
Expression of CCR2 on monocytes and macrophages in chronically inflamed skin in atopic dermatitis and psoriasis. Acta Derm Venereol (2004) 0.91
Two cases of severe refractory chronic idiopathic urticaria treated with omalizumab. Acta Derm Venereol (2010) 0.91
Increased levels of circulating Th17 cells in quiescent versus active Crohn's disease. J Crohns Colitis (2012) 0.91
Kinetics and differential expression of the skin-related chemokines CCL27 and CCL17 in psoriasis, atopic dermatitis and allergic contact dermatitis. Exp Dermatol (2011) 0.88
The effect of salt reduction on sensory quality and microbial growth in hotdog sausages, bacon, ham and salami. Meat Sci (2013) 0.87
CXCL13 predicts disease activity in early rheumatoid arthritis and could be an indicator of the therapeutic 'window of opportunity'. Arthritis Res Ther (2014) 0.87
Comparison of the effects of vitamin D products in a psoriasis plaque test and a murine psoriasis xenograft model. J Transl Med (2009) 0.87
Tumor necrosis factor-alpha-induced CTACK/CCL27 (cutaneous T-cell-attracting chemokine) production in keratinocytes is controlled by nuclear factor kappaB. Cytokine (2005) 0.86
Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines--a possible link between reduced skin barrier function and inflammation? Exp Dermatol (2011) 0.85
Increased plasma levels of IL-21 and IL-23 in spondyloarthritis are not associated with clinical and MRI findings. Rheumatol Int (2010) 0.84
Decreased plasma levels of soluble CD18 link leukocyte infiltration with disease activity in spondyloarthritis. Arthritis Res Ther (2014) 0.84
Therapeutic patient education in atopic dermatitis: worldwide experiences. Pediatr Dermatol (2013) 0.84
A long term case series study of the effect of omalizumab on chronic spontaneous urticaria. Ann Dermatol (2013) 0.84
Difficult to control atopic dermatitis. World Allergy Organ J (2013) 0.84
Cobalt-chromium-molybdenum alloy causes metal accumulation and metallothionein up-regulation in rat liver and kidney. Basic Clin Pharmacol Toxicol (2007) 0.83
Concomitant Sweet's syndrome and relapsing polychondritis. Acta Derm Venereol (2007) 0.83
Omalizumab induced remission of idiopathic anaphylaxis in a patient suffering from indolent systemic mastocytosis. Acta Derm Venereol (2014) 0.83
TARC augments TNF-alpha-induced CTACK production in keratinocytes. Exp Dermatol (2004) 0.82
Connubial tinea gladiatorum due to Trichophyton mentagrophytes. Mycoses (2010) 0.82
Linkage of atopic dermatitis to chromosomes 4q22, 3p24 and 3q21. Hum Genet (2009) 0.81
Therapeutic patient education in children with atopic dermatitis: position paper on objectives and recommendations. Pediatr Dermatol (2013) 0.80
Abatacept is a promising treatment for patients with disseminated morphea profunda: presentation of two cases. Acta Derm Venereol (2011) 0.80
Contact allergy and allergic contact dermatitis in children - a review of current data. Contact Dermatitis (2011) 0.80
Inflammation-induced alterations in the skin barrier function: implications in atopic dermatitis. Chem Immunol Allergy (2012) 0.80
Glucocorticoid-induced tumour necrosis factor receptor (GITR) and its ligand (GITRL) in atopic dermatitis. Acta Derm Venereol (2006) 0.79
Evaluation of FITC-induced atopic dermatitis-like disease in NC/Nga mice and BALB/c mice using computer-assisted stereological toolbox, a computer-aided morphometric system. Int Arch Allergy Immunol (2009) 0.79
Adalimumab treatment in Crohn's disease does not induce early changes in regulatory T cells. Scand J Gastroenterol (2011) 0.79
Thymus- and activation-regulated chemokine (TARC/CCL17) induces a Th2-dominated inflammatory reaction on intradermal injection in mice. Exp Dermatol (2004) 0.79
Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) of hands and feet in an 83-year-old man. Acta Derm Venereol (2013) 0.79
Soluble OX40L is associated with presence of autoantibodies in early rheumatoid arthritis. Arthritis Res Ther (2014) 0.78
Clonal spread of Staphylococcus aureus with reduced susceptibility to oxacillin in a dermatological hospital unit. Acta Derm Venereol (2006) 0.78
IL-25 induces both inflammation and skin barrier dysfunction in atopic dermatitis. Chem Immunol Allergy (2012) 0.78
Advances in the diagnosis and therapeutic management of atopic dermatitis. Drugs (2014) 0.78
A retrospective study of six cases of severe recalcitrant atopic dermatitis treated with long-term extracorporeal photopheresis. Acta Derm Venereol (2010) 0.78
Biodistribution and PET imaging of a novel [68Ga]-anti-CD163-antibody conjugate in rats with collagen-induced arthritis and in controls. Mol Imaging Biol (2015) 0.78
Ethylene-Diamine-Tetra-Acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cells. J Immunol Methods (2009) 0.78
Therapy of severe atopic dermatitis in adults. J Dtsch Dermatol Ges (2012) 0.78
Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation. APMIS (2008) 0.78
T-cell receptor excision circles (TREC) in CD4+ and CD8+ T-cell subpopulations in atopic dermatitis and psoriasis show major differences in the emission of recent thymic emigrants. Acta Derm Venereol (2008) 0.77
A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis. Int Immunopharmacol (2010) 0.77
IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis. Arthritis Res Ther (2013) 0.77
Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course. PLoS One (2013) 0.77
CCL27 expression is regulated by both p38 MAPK and IKKβ signalling pathways. Cytokine (2011) 0.77
Surfactant protein D in atopic dermatitis and psoriasis. Exp Dermatol (2006) 0.76
Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis. PLoS One (2013) 0.76
CD4+ T cell depletion changes the cytokine environment from a TH1/TH2 response to a TC17-like response in a murine model of atopic dermatitis. Int Immunopharmacol (2011) 0.76
Interleukin-21 restrains tumor growth and induces a substantial increase in the number of circulating tumor-specific T cells in a murine model of malignant melanoma. Cytokine (2009) 0.76
A genome-wide search for linkage to allergic rhinitis in Danish sib-pair families. Eur J Hum Genet (2012) 0.75
A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta Derm Venereol (2015) 0.75
[Biological treatment of psoriasis and psoriatic arthritis]. Ugeskr Laeger (2008) 0.75
Topical Calcineurin Inhibitors, Topical Glucocorticoids and Cancer in Children: A Nationwide Study. Acta Derm Venereol (2016) 0.75
[Clinical signs of Cushing's syndrome after long-term local application of steroid in the oral cavity]. Ugeskr Laeger (2012) 0.75
Disease models--one size does not fit all. Drug Discov Today (2010) 0.75
Proximity ligation assay combined with flow cytometry is a powerful tool for the detection of cytokine receptor dimerization. Cytokine (2013) 0.75
[Frontal fibrosing alopecia is a variant of lichen planopilaris]. Ugeskr Laeger (2015) 0.75
Transient telangiectatic purpura after axillary dissection: a postoperative phenomenon. Acta Derm Venereol (2013) 0.75
Allergic contact dermatitis in Danish children referred for patch testing - a nationwide multicentre study. Contact Dermatitis (2013) 0.75
Subcutaneous Phaeohyphomycosis due to Alternaria dennisii in an Immunocompromised Patient. Acta Derm Venereol (2016) 0.75
[Arsenical keratosis treated by dermatome shaving]. Ugeskr Laeger (2014) 0.75
Cardiovascular Risk is not Increased in Patients with Chronic Urticaria: A Retrospective Population-based Cohort Study. Acta Derm Venereol (2017) 0.75
The "Alarmins" HMBG1and Interleukin-33 Downregulate the Structural Skin Barrier. Acta Derm Venereol (2016) 0.75
Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. Dermatology (2017) 0.75